This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Davie, M. (2015). Doing more for mental health. Archives of Disease in Childhood—Education & Practice Edition, 101(2), 77–81. doi:10.1136/archdischild-2015-308344DavieM.2015Doing more for mental healthArchives of Disease in Childhood—Education & Practice Edition1012778110.1136/archdischild-2015-308344Open DOISearch in Google Scholar
McLaughlin, M., Kotis, D., Thomson, K., Harrison, M., Fennessy, G., Postelnick, M., & Scheetz, M. H. (2013). Effects on patient care caused by drug shortages: A survey. Journal of Managed Care Pharmacy, 19(9), 783–788. doi:10.18553/jmcp.2013.19.9.783McLaughlinM.KotisD.ThomsonK.HarrisonM.FennessyG.PostelnickM.ScheetzM. H.2013Effects on patient care caused by drug shortages: A surveyJournal of Managed Care Pharmacy19978378810.18553/jmcp.2013.19.9.783Open DOISearch in Google Scholar
Sunkel, C., & Viljoen, M. (2017). Shortage of psychiatric medications in South Africa. The Lancet Psychiatry, 4(1), 15–16. doi:10.1016/s2215-0366(16)30422-9SunkelC.ViljoenM.2017Shortage of psychiatric medications in South AfricaThe Lancet Psychiatry41151610.1016/s2215-0366(16)30422-9Open DOISearch in Google Scholar
Omorodion, J. O., Algahtani, R. M., Zocchi, M. S., Fox, E. R., Pines, J. M., & Kaminski, H. J. (2017). Shortage of generic neurologic therapeutics. Neurology, 89(24), 2431–2437. doi:10.1212/wnl.0000000000004737.OmorodionJ. O.AlgahtaniR. M.ZocchiM. S.FoxE. R.PinesJ. M.KaminskiH. J.2017Shortage of generic neurologic therapeuticsNeurology89242431243710.1212/wnl.000000000000473729142086Open DOISearch in Google Scholar
Yazed Sulaiman Al-Ruthia, Wael Mansy, Mohammad Barasin, Yazeed Mohammad Ghawaa, Mohammed Al Sultan, Mohammad A. AlsenaidySolaiman Alhawas a, Sultan AlGhadeer (2017). Shortage of psychotropic medications in community pharmacies in Saudi Arabia: Causes and solutions Saudi Pharmaceutical Journal, 25, 744–749Al-RuthiaYazed SulaimanMansyWaelBarasinMohammadGhawaaYazeed MohammadAl SultanMohammedAlsenaidyMohammad A.AlhawasSolaimana,AlGhadeerSultan2017Shortage of psychotropic medications in community pharmacies in Saudi Arabia: Causes and solutionsSaudi Pharmaceutical Journal2574474910.1016/j.jsps.2016.10.013550673528725147Search in Google Scholar
Desmarais, J. E., Beauclair, L., Margolese, H. C. (2011). Switching from brand-name to generic psychotropic medications: a literature review. CNS Neurosci Ther. 17(6): 750–60.DesmaraisJ. E.BeauclairL.MargoleseH. C.2011Switching from brand-name to generic psychotropic medications: a literature reviewCNS Neurosci Ther.1767506010.1111/j.1755-5949.2010.00210.x649385321114789Search in Google Scholar
Kluznik. J. C., Walbek, N. H., Farnsworth, M. G., et al. (2001). Clinical effects of a randomized switch of patients from clozaril to generic clozapine. J Clin Psychiatry, 62 (Suppl 5): 14–7KluznikJ. C.WalbekN. H.FarnsworthM. G.2001Clinical effects of a randomized switch of patients from clozaril to generic clozapineJ Clin Psychiatry62Suppl 5147Search in Google Scholar
Petrou, P., Vandoros, S. (2015). Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access or quality of treatment. Health Policy, 119(5), 563–568.PetrouP.VandorosS.2015Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access or quality of treatmentHealth Policy119556356810.1016/j.healthpol.2015.03.00425837234Search in Google Scholar
Petrou, P., (2021) The 2019 introduction of the new National Healthcare System in Cyprus. Health Policy 125 (3), 284–289PetrouP.2021The 2019 introduction of the new National Healthcare System in CyprusHealth Policy125328428910.1016/j.healthpol.2020.12.01833516561Search in Google Scholar
https://www.eahp.eu/practice-and-policy/medicines-shortageshttps://www.eahp.eu/practice-and-policy/medicines-shortagesSearch in Google Scholar
Al Ruthia, Y. S., Al Kofide, H., Al Ajmi, R., Balkhi, B., Alghamdi, A., Al Nasser, A., Alathbah, A. (2017). Drug shortages in large hospitals in Riyadh: a cross-sectional study. Annals of Saudi medicine, 37(5), 375–385. doi:10.5144/0256-4947.2017.375Al RuthiaY. S.Al KofideH.Al AjmiR.BalkhiB.AlghamdiA.Al NasserA.AlathbahA.2017Drug shortages in large hospitals in Riyadh: a cross-sectional studyAnnals of Saudi medicine37537538510.5144/0256-4947.2017.375607419128988252Open DOISearch in Google Scholar
Gray, A., Manasse, H. R. (2012). Shortage of medicines: a complex global challenge. Bulletin of the World Health Organization 154–154A.GrayA.ManasseH. R.2012Shortage of medicines: a complex global challengeBulletin of the World Health Organization154154A10.2471/BLT.11.101303331420322461706Search in Google Scholar
Bochenek, T., Abilova, V., Alkan, A., Asanin, B., de Miguel Beriain, I., Besovic, Z., Vella Bonanno, P., Bucsics, A., Davidescu, M., De Weerdt, E., Duborija-Kovacevic, N., Fürst, J., Gaga, M., Gailīte, E., Gulbinovič, J., Gürpınar, E. U., Hankó, B., Hargaden, V., Hotvedt, T.A., Hoxha, I., Huys, I., Inotai, A., Jakupi, A., Jenzer, H., Joppi, R., Laius, O., Lenormand, M-C., Makridaki, D., Malaj, A., Margus, K., Marković-Peković, V., Miljković, N., de Miranda, J. L., Primožič, S., Rajinac, D., Schwartz, D. G., Šebesta, R., Simoens, S., Slaby, J., Sović-Brkičić, L,, Tesar, T., Tzimis, L., Warmińska, E. and Godman, B. (2018). Systemic measures and legislative and organizational frameworks aimed at preventing or mitigating drug shortages in 28 European and Western Asian countries. Front. Pharmacol. 8, 942. doi: 10.3389/fphar.2017.00942BochenekT.AbilovaV.AlkanA.AsaninB.de Miguel BeriainI.BesovicZ.Vella BonannoP.BucsicsA.DavidescuM.De WeerdtE.Duborija-KovacevicN.FürstJ.GagaM.GailīteE.GulbinovičJ.GürpınarE. U.HankóB.HargadenV.HotvedtT.A.HoxhaI.HuysI.InotaiA.JakupiA.JenzerH.JoppiR.LaiusO.LenormandM-C.MakridakiD.MalajA.MargusK.Marković-PekovićV.MiljkovićN.de MirandaJ. L.PrimožičS.RajinacD.SchwartzD. G.ŠebestaR.SimoensS.SlabyJ.Sović-BrkičićL.TesarT.TzimisL.WarmińskaE.GodmanB.2018Systemic measures and legislative and organizational frameworks aimed at preventing or mitigating drug shortages in 28 European and Western Asian countriesFront. Pharmacol.894210.3389/fphar.2017.00942577907229403372Open DOISearch in Google Scholar
Finnish Medicines Agency. Helsinki: Finnish Medicines Agency; 2019. www.fimea.fi/web/en/supervision/mandatory_reserve_supplies. Accessed 28 March 2019.Finnish Medicines AgencyHelsinki: Finnish Medicines Agency2019www.fimea.fi/web/en/supervision/mandatory_reserve_supplies. Accessed 28 March 2019.Search in Google Scholar
Weaver, J. M. (2010). Why are there so many drug shortages? Anesth Prog. 57, 89–90WeaverJ. M.2010Why are there so many drug shortages?Anesth Prog57899010.2344/0003-3006-57.3.89331527220843222Search in Google Scholar
Petrou, P., Vandoros, S. (2018). Healthcare reforms in Cyprus 2013–2017: Does the crisis mark the end of the healthcare sector as we know it? Health Policy 122, 75–80PetrouP.VandorosS.2018Healthcare reforms in Cyprus 2013–2017: Does the crisis mark the end of the healthcare sector as we know it?Health Policy122758010.1016/j.healthpol.2017.11.00429274916Search in Google Scholar